Nature Portfolio
Melanie Senior is an experienced biopharma reporter and science writer with a focus on healthcare, pricing, and market access issues. Since January 2018, Melanie has worked as a biopharma reporter and science writer for Nature Portfolio while also serving as a specialist writer in life sciences for Evaluate Ltd., Nature, IN VIVO, and various biotech companies. Prior roles include biopharma writer and analyst at EY, senior analyst and writer at Real Endpoints, and bureau chief in Europe for Elsevier Business Intelligence. Melanie holds a Bachelor's degree in Natural Sciences from the University of Cambridge and multiple master's degrees in International Health Technology Assessment, Pricing and Reimbursement from The University of Sheffield and in Nutrition Sciences from St. Mary's University, Twickenham.
Nature Portfolio
Springer Nature publishes journals, databases and online products and services across the life, physical and applied sciences and, most recently, clinical medicine. Content encompasses daily news from award-winning journalists, expert opinion and practical methodology, and more high impact research and reviews than any science publisher. Over 70 journals are published, some in association with prestigious academic societies. Nature Portfolio provides news content through Nature News. Scientific career information and free job postings are offered on Naturejobs. Nature was first published in 1869. Springer Nature has its principal offices in London, New York and Tokyo with offices in offices in Basingstoke, Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Melbourne, Munich, Paris, San Francisco, Seoul and Washington DC.